HHS Pulls Policy on Drug Discounts for Contract Pharmacies

June 21, 2021, 9:31 AM

The Health and Human Services Department is withdrawing a proclamation broadly calling on drugmakers to offer hotly contested price discounts for low-income health-care providers in an attempt to fend off litigation, but the agency won’t back down from fighting individual companies.

The HHS’ 2020 advisory opinion calling on pharmaceutical companies participating in the government’s 340B program to deliver drugs purchased by health centers to their contract pharmacies has been withdrawn in the “interest of avoiding confusion and unnecessary litigation,” the agency said in a June 18 court filing.

The withdrawal, however, “does not impact the ongoing efforts” to hold ...

To read the full article log in.

Learn more about a Bloomberg Law subscription.